[{"NetIncomeLoss_1_Q3_USD":-58228000.0,"LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_0_Q3_USD":2925000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q3_USD":18.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":11000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q3_USD":1500000.0,"DerivativeAssets_0_Q3_USD":109000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-255866000.0,"StockIssuedDuringPeriodValueNewIssues_3_Q3_USD":193948000.0,"LiabilitiesFairValueDisclosure_0_Q3_USD":173000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":3371048.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_3_Q3_USD":0.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q3_USD":0.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":15000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":11083000.0,"AssetsCurrent_0_Q3_USD":970866000.0,"OtherNoncashIncomeExpense_3_Q3_USD":-18000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":15950786.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":15950786.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":11447000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":30347000.0,"LessorOperatingLeasePaymentsToBeReceivedThreeYears_0_Q3_USD":3096000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.01,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":193948000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.01,"AccruedLiabilitiesCurrent_0_Q3_USD":11531000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":20.6,"ShareBasedCompensation_3_Q3_USD":36521000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_0_Q3_USD":13.8,"Assets_0_Q3_USD":1070306000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":630495000.0,"CommonStockSharesIssued_0_Q3_shares":119795216.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":10731000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":32976000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":107490702.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":105217770.0,"Revenues_1_Q3_USD":9393000.0,"Revenues_3_Q3_USD":18844000.0,"CommonStockValue_0_Q3_USD":1524000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_1_Q3_USD":-540000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_3_Q3_USD":-339000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_3_Q3_USD":1074000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":6410000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":56000.0,"AssetsFairValueDisclosure_0_Q3_USD":957244000.0,"LessorOperatingLeasePaymentsToBeReceived_0_Q3_USD":10621000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":100262000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":15.77,"ResearchAndDevelopmentExpense_1_Q3_USD":53704000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":157872000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":-3819000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":625227000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_1_Q3_USD":0.0,"GeneralAndAdministrativeExpense_1_Q3_USD":15805000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":42332000.0,"MarketableSecuritiesCurrent_0_Q3_USD":610154000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"OperatingLeaseLiability_0_Q3_USD":69915000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3_Q3_USD":11133000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":433557000.0,"Liabilities_0_Q3_USD":187756000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":351047000.0,"OtherAssetsNoncurrent_0_Q3_USD":3858000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":147000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-58768000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-174088000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_3_Q3_USD":0.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":65407000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":2536000.0,"CommonStockSharesAuthorized_0_Q3_shares":400000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":9388000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":377000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":36521000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":13252000.0,"RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_3_Q3_USD":93000.0,"RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_1_Q3_USD":5000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-97763000.0,"MarketableSecuritiesNoncurrent_0_Q3_USD":20341000.0,"LessorOperatingLeasePaymentsToBeReceivedFourYears_0_Q3_USD":876000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":10391000.0,"LiabilitiesCurrent_0_Q3_USD":105413000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":271598000.0,"AccountsPayableCurrent_0_Q3_USD":2806000.0,"NonoperatingIncomeExpense_3_Q3_USD":7611000.0,"NonoperatingIncomeExpense_1_Q3_USD":1944000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":352547000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":9665000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.09,"NetIncomeLoss_3_Q3_USD":-173749000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":42265000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":32000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"IncomeLossAttributableToParent_1_Q3_USD":-58172000.0,"IncomeLossAttributableToParent_3_Q3_USD":-173749000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":-540000.0,"OperatingLeasePayments_3_Q3_USD":7200000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":874357.0,"LesseeOperatingLeaseDiscountRate_0_Q3_pure":0.09,"AdditionalPaidInCapital_0_Q3_USD":1480315000.0,"SubleaseIncome_1_Q3_USD":900000.0,"SubleaseIncome_3_Q3_USD":2800000.0,"LessorOperatingLeasePaymentsToBeReceivedTwoYears_0_Q3_USD":3009000.0,"NumberOfOperatingSegments_3_Q3_Segment":1.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":-339000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q3_shares":11775333.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":687523000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":4508000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":617360.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":13252000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":36521000.0,"DerivativeLiabilities_0_Q3_USD":173000.0,"PreferredStockSharesAuthorized_0_Q3_shares":40000000.0,"OperatingExpenses_3_Q3_USD":200204000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":9010000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":10.63,"PreferredStockValue_0_Q3_USD":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":25.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":28015000.0,"OperatingIncomeLoss_1_Q3_USD":-60116000.0,"OperatingIncomeLoss_3_Q3_USD":-181360000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":1070306000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":18751000.0,"OperatingExpenses_1_Q3_USD":69509000.0,"LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_0_Q3_USD":715000.0,"CommonStockSharesOutstanding_0_Q3_shares":119795216.0,"LeaseCost_1_Q3_USD":2800000.0,"LeaseCost_3_Q3_USD":8300000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-599300000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":5437269.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":13520065.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":4880000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":630133000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":16557000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q3_USD":0.0,"StockholdersEquity_0_Q3_USD":882550000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":379000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.54,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.65,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":1900000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-17920000.0,"Ticker":"DNLI","CIK":"1714899","name":"DENALI THERAPEUTICS INC.","OfficialName":"Denali Therapeutics Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"3477413158.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20201105"}]